Literature DB >> 1883530

Use of liposomes, viral capsids, and nanoparticles as DNA carriers.

W M Bertling1, M Gareis, V Paspaleeva, A Zimmer, J Kreuter, E Nürnberg, P Harrer.   

Abstract

We tested a variety of liposomes for parameters such as DNA binding capacity and DNase I protection of incorporated and attached DNA to elucidate their use as vehicles for DNA transfer into cells and animals. The results were compared to other potential DNA vehicles, empty viral capsids, and nanoparticles. Maximal binding capacity was achieved for positively charged nanoparticles, DNase I protection was observed for most preparations with neosome preparations being least efficient. The uptake of radiolabeled DNA by cells in culture was determined for cationic and nonionic surfactant vesicles, viral capsids, and nanoparticles. Cellular DNA uptake was best for dioleoyl-derived positively charged liposomes (N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium chloride; DOTMA) and the DNA could be shown to be physiologically active. The recombination rate for DNA fragments transfected in polyoma capsids in live mice was higher than for liposome mediated transfection. Homologous recombination could be observed for both DOTMA and polyoma-mediated DNA transfer.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1883530

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  10 in total

1.  Antisense delivery using protamine-oligonucleotide particles.

Authors:  M Junghans; J Kreuter; A Zimmer
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

2.  Enhanced in vitro oligonucleotide and plasmid DNA transport by VP1 virus-like particles.

Authors:  S Henke; A Rohmann; W M Bertling; T Dingermann; A Zimmer
Journal:  Pharm Res       Date:  2000-09       Impact factor: 4.200

Review 3.  Oligo/polynucleotide-based gene modification: strategies and therapeutic potential.

Authors:  R Geoffrey Sargent; Soya Kim; Dieter C Gruenert
Journal:  Oligonucleotides       Date:  2011-03-21

4.  In vitro studies of liposome-mediated gene transfer into head and neck cancer cell lines.

Authors:  B Wollenberg; S Lang; B Schmitt; E Kastenbauer; R Zeidler
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

5.  Efficacy of siRNA nanocapsules targeted against the EWS-Fli1 oncogene in Ewing sarcoma.

Authors:  Nedjma Toub; Jean-Rémi Bertrand; Ali Tamaddon; Hind Elhamess; Hervé Hillaireau; Andrei Maksimenko; Jean Maccario; Claude Malvy; Elias Fattal; Patrick Couvreur
Journal:  Pharm Res       Date:  2006-05-02       Impact factor: 4.200

6.  A non-ionic vesicle lipid enhances mastoparan-stimulated GTPase activity of heterotrimeric G-proteins.

Authors:  B Nürnberg; R Hoppe; U Rümenapp; R Harhammer; E Nürnberg
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

7.  Participation of Macrogolstearate 400 lamellar phases in hydrophilic creams and vesicles.

Authors:  V Paspaleeva-Kühn; E Nürnberg
Journal:  Pharm Res       Date:  1992-10       Impact factor: 4.200

8.  Promising plasmid DNA vector based on APTES-modified silica nanoparticles.

Authors:  Tuck-yun Cheang; Bing Tang; An-wu Xu; Guang-qi Chang; Zuo-jun Hu; Wei-ling He; Zhou-hao Xing; Jian-bo Xu; Mian Wang; Shen-ming Wang
Journal:  Int J Nanomedicine       Date:  2012-02-23

9.  Synthesis and characterization of layered double hydroxides and their potential as nonviral gene delivery vehicles.

Authors:  Blake Balcomb; Moganavelli Singh; Sooboo Singh
Journal:  ChemistryOpen       Date:  2014-12-18       Impact factor: 2.911

10.  The analytic network process for the pharmaceutical sector: Multi criteria decision making to select the suitable method for the preparation of nanoparticles.

Authors:  Ramaiyan Velmurugan; Subramanian Selvamuthukumar
Journal:  Daru       Date:  2012-10-18       Impact factor: 3.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.